狗中Mesocestoides vogae感染:可能与球菌病混为一谈
Yasuyuki Morishima1, Hiromu Sugiyama1
1Department of Parasitology, National Institute of Infectious Diseases, Japan.
Japanese journal of infectious diseases
|March 2, 2025
概括
兽医们错误地将狗中的Mesocestoides vogae带虫识别为 Echinococcus multilocularis. 在狗中发现的带虫是 Echinococcus multilocularis. 分子分析证实了Mesocestoides物种,而除草剂治疗解决了受影响狗的腹.
科学领域:
- 兽医寄生虫学 兽医寄生虫学
- 分子诊断学 分子诊断学
- 狗的健康 狗的健康
背景情况:
- 在狗中,Mesocestoides带状可以引起胃肠道问题.
- 错误识别带虫物种可能导致错误的疾病报告和治疗.
- Echinococcus multilocularis是一种需要报告的疾病,需要立即进行公共卫生干预.
研究的目的:
- 为了识别导致6只狗腹的带虫物种.
- 为了区分Mesocestoides spp. 的不同. 从可能需要报告的寄生虫,如 Echinococcus multilocularis.
- 报告狗中Mesocestoides感染的临床表现和成功治疗情况.
主要方法:
- 从便样本中回收的条虫标本的形态检查.
- 用线粒体cox1和12SrDNA基因进行物种识别的分子分析.
- 临床案例审查六只狗出现腹和带虫流产.
主要成果:
- 形态分析显示,带状虫有四个吸管在scolex和没有 rostellum.
- 分子测序证实了所有六个病例都是Mesocestoides vogae.
- 受影响的狗经历了虫杀虫剂治疗后腹的立即解决.
结论:
- 由于相似的形态,Mesocestoides vogae 可能会被误认为是 Echinococcus multilocularis,特别是在不成熟的阶段.
- 通过分子方法准确识别物种对于正确的诊断和管理至关重要.
- 及时使用甲虫药物治疗有效地消除了与狗中Mesocestoides感染相关的临床症状.
相关概念视频
Toxidromes: Clinical Features
175
Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
175
Arboviral Encephalitis
59
Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
59
Anthelminthic Agents
103
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
103
Encephalitis l: Introduction
15
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
15
Encephalitis ll: Pathophysiology
22
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
22
Hepatic Encephalopathy
53
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
53


